Millipore Sigma Vibrant Logo

208745 Calpain Inhibitor VI - CAS 190274-53-4 - Calbiochem

View This Product on Sigma-Aldrich
208745
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
190274-53-4C₁₇H₂₅FN₂O₄S

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
208745-1MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 1 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      208745-5MGCN
      在庫状況検索中…
      現在国内在庫なし
現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル 5 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewA potent, cell-permeable, reversible inhibitor of calpain (IC50 = 7.5 nM for µ-calpain and 78 nM for m-calpain). Also potently inhibits cathepsin B (IC50 = 15 nM) and L (IC50 = 1.6 nM). Reduces bFGF-induced angiogenesis in rat cornea and prevents selenite cataract formation. Reduces A23187-induced nuclear opacity and proteolysis of crystallins and α-spectrin in cultured lenses.
          Catalogue Number208745
          Brand Family Calbiochem®
          SynonymsN-(4-Fluorophenylsulfonyl)-L-valyl-L-leucinal, SJA6017
          References
          ReferencesInoue, J., et al. 2003. J. Med. Chem. 46, 868.
          Tamada, Y., et al. 2001. Curr. Eye Res. 22, 280.
          Mathur, P., et al. 2000. Curr. Eye Res. 21, 926.
          Nath, R., et al. 2000. Biochem. Biophys. Res. Commun. 274, 16.
          Tamada, Y., et al. 2000. J. Ocul. Pharmacol. Ther. 16, 271.
          Fukiage, C., et al. 1998. Curr. Eye Res. 17, 623.
          Fukiage, C., et al. 1997. Biochim. Biophys. Acta 1361, 304.
          Product Information
          CAS number190274-53-4
          ATP CompetitiveN
          DeclarationSold under license of U.S. Patent 6,551,999
          FormWhite lyophilized solid
          Hill FormulaC₁₇H₂₅FN₂O₄S
          Chemical formulaC₁₇H₂₅FN₂O₄S
          ReversibleY
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Targetµ-calpain
          Primary Target IC<sub>50</sub>7.5 nM for µ-calpain and 78 nM for m-calpain; 15 nM and 1.6 nM against cathepsin B and L, respectively
          Purity≥97% by HPLC
          Physicochemical Information
          Cell permeableY
          Peptide Sequence4-Fluorophenylsulfonyl-Val-Leu-CHO
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          カタログ番号 GTIN
          208745-1MGCN 04055977202816
          208745-5MGCN 04055977202823

          Documentation

          Calpain Inhibitor VI - CAS 190274-53-4 - Calbiochem (M)SDS

          タイトル

          英語版製品安全データシート((M)SDS) 

          Calpain Inhibitor VI - CAS 190274-53-4 - Calbiochem 試験成績書(CoA)

          タイトルロット番号
          208745

          参考資料

          参考資料の概要
          Inoue, J., et al. 2003. J. Med. Chem. 46, 868.
          Tamada, Y., et al. 2001. Curr. Eye Res. 22, 280.
          Mathur, P., et al. 2000. Curr. Eye Res. 21, 926.
          Nath, R., et al. 2000. Biochem. Biophys. Res. Commun. 274, 16.
          Tamada, Y., et al. 2000. J. Ocul. Pharmacol. Ther. 16, 271.
          Fukiage, C., et al. 1998. Curr. Eye Res. 17, 623.
          Fukiage, C., et al. 1997. Biochim. Biophys. Acta 1361, 304.

          カタログ

          タイトル
          Caspases and other Apoptosis Related Tools Brochure
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision19-February-2014 JSW
          SynonymsN-(4-Fluorophenylsulfonyl)-L-valyl-L-leucinal, SJA6017
          DescriptionA cell-permeable peptide aldehyde that acts as a potent and reversible inhibitor of calpain (IC50 = 7.5 nM for µ-calpain and 78 nM for m-calpain). Also potently inhibits cathepsin B (IC50 = 15 nM) and cathepsin L (IC50 = 1.6 nM). Reduces βFGF-induced angiogenesis in rat cornea and prevents selenite cataract formation in rats. Reduces A23187-induced nuclear opacity and proteolysis of crystallins and α-spectrin in cultured rat lenses.
          FormWhite lyophilized solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number190274-53-4
          Chemical formulaC₁₇H₂₅FN₂O₄S
          Peptide Sequence4-Fluorophenylsulfonyl-Val-Leu-CHO
          Structure formulaStructure formula
          Purity≥97% by HPLC
          SolubilityDMSO (5 mg/ml)
          Storage Protect from light
          -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesInoue, J., et al. 2003. J. Med. Chem. 46, 868.
          Tamada, Y., et al. 2001. Curr. Eye Res. 22, 280.
          Mathur, P., et al. 2000. Curr. Eye Res. 21, 926.
          Nath, R., et al. 2000. Biochem. Biophys. Res. Commun. 274, 16.
          Tamada, Y., et al. 2000. J. Ocul. Pharmacol. Ther. 16, 271.
          Fukiage, C., et al. 1998. Curr. Eye Res. 17, 623.
          Fukiage, C., et al. 1997. Biochim. Biophys. Acta 1361, 304.